Michiko Watanabe Selected Research

Michiko Watanabe Research Topics

Disease

11	Hypoxia (Hypoxemia) 03/2020 - 08/2002
6	Neoplasms (Cancer) 09/2020 - 04/2005
5	Congenital Heart Defects (Congenital Heart Defect) 01/2021 - 02/2014
5	Glioma (Gliomas) 09/2010 - 07/2002
4	Heart Failure 09/2020 - 04/2010
3	Congenital Abnormalities (Deformity) 01/2021 - 02/2014
3	Fetal Alcohol Spectrum Disorders 01/2021 - 04/2015
2	Thrombosis (Thrombus) 09/2022 - 03/2020
2	Stroke (Strokes) 01/2022 - 01/2020
2	Chemical and Drug Induced Liver Injury 01/2021 - 01/2021
2	Cardiomyopathies (Cardiomyopathy) 09/2020 - 04/2010
2	Atrial Fibrillation 01/2020 - 09/2018
2	Abdominal Aortic Aneurysm 07/2016 - 01/2016
2	Aortic Aneurysm (Aneurysm, Aortic) 01/2014 - 04/2010
2	Breast Neoplasms (Breast Cancer) 10/2012 - 05/2008
2	Lymphatic Metastasis 04/2011 - 01/2007
2	Thyroid Neoplasms (Thyroid Cancer) 03/2011 - 01/2007
2	Endometrial Neoplasms (Endometrial Cancer) 05/2008 - 01/2007
2	Brain Neoplasms (Brain Tumor) 09/2006 - 07/2002
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 09/2006 - 07/2003
1	Aneurysm (Aneurysms) 01/2022
1	Median Arcuate Ligament Syndrome 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Hemorrhage 01/2022
1	Cardiotoxicity 09/2020
1	Pulmonary Embolism 03/2020
1	Tachycardia (Tachyarrhythmias) 03/2019
1	Neuroleptic Malignant Syndrome 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2018
1	Thrombocytopenia (Thrombopenia) 12/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Hypertension (High Blood Pressure) 03/2017
1	Pulmonary Hypertension 03/2017
1	Communicable Diseases (Infectious Diseases) 02/2017
1	Type 2 Diabetes Mellitus (MODY) 02/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2017

Drug/Important Bio-Agent (IBA)

5	Ethanol (Ethyl Alcohol)IBA 01/2021 - 02/2014
3	Pharmaceutical PreparationsIBA 01/2021 - 09/2006
3	Oxygen (Dioxygen)IBA 04/2018 - 01/2006
3	Transcription Factors (Transcription Factor)IBA 07/2013 - 09/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 03/2004
3	Protein Isoforms (Isoforms)IBA 09/2010 - 03/2004
3	Proteins (Proteins, Gene)FDA Link 10/2009 - 04/2005
3	Messenger RNA (mRNA)IBA 01/2007 - 07/2002
2	Betaine (C.B.B.)FDA Link 01/2021 - 11/2017
2	Biomarkers (Surrogate Marker)IBA 03/2017 - 01/2014
2	CreatinineIBA 02/2017 - 01/2014
2	TeratogensIBA 09/2014 - 06/2013
2	Contrast MediaIBA 01/2014 - 01/2009
2	Tamoxifen FDA LinkGeneric 10/2012 - 05/2008
2	Estrogens (Estrogen)FDA Link 10/2012 - 05/2008
2	Estrogen ReceptorsIBA 10/2012 - 05/2008
2	Fibronectins (Fibronectin)IBA 04/2011 - 01/2007
2	Monoclonal AntibodiesIBA 03/2011 - 01/2007
2	Indicators and Reagents (Reagents)IBA 10/2009 - 01/2006
2	nicaravenIBA 09/2006 - 07/2003
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2004 - 03/2004
1	hydroxide ionIBA 01/2021
1	Choline (Choline Chloride)IBA 01/2021
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2021
1	AnthracyclinesIBA 09/2020
1	Trastuzumab (Herceptin)FDA Link 09/2020
1	Antineoplastic Agents (Antineoplastics)IBA 09/2020
1	Cytidine Monophosphate (CMP)IBA 03/2019
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 12/2018
1	AntibodiesIBA 12/2018
1	rho-Associated KinasesIBA 04/2018
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2018
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 04/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2018
1	LigandsIBA 04/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2017
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 03/2017
1	Insulin (Novolin)FDA Link 02/2017
1	SugarsIBA 02/2017
1	Hemoglobins (Hemoglobin)IBA 02/2017
1	NitrogenIBA 02/2017
1	Urea (Carbamide)FDA LinkGeneric 02/2017
1	PotassiumIBA 02/2017
1	Glucose (Dextrose)FDA LinkGeneric 02/2017
1	N,N'- bis((2- chloroethyl)nitrosocarbamoyl)cystamine (CNCC)IBA 11/2016

Therapy/Procedure

6	Therapeutics 09/2020 - 09/2006
4	Stents 09/2022 - 01/2014
3	Maze Procedure 03/2019 - 11/2013
2	Heart-Assist Devices 09/2020 - 12/2018
2	Endarterectomy (Thromboendarterectomy) 03/2020 - 03/2017
1	Activities of Daily Living (ADL) 01/2022
1	Drug Therapy (Chemotherapy) 09/2020
1	Extracorporeal Membrane Oxygenation 03/2020
1	Embolectomy 03/2020
1	Wearable Electronic Devices 01/2020
1	Catheter Ablation 03/2019
1	Plasma Exchange 12/2018
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 03/2017